This inventor holds 1 USPTO granted patent. Top assignee: Ucbbiopharma Srl. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Jérôme Albert J Hoet
Introduction
Jérôme Albert J Hoet is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with D1 receptors. His work is essential for advancing treatments for various diseases.
Latest Patents
Jérôme holds a patent for a substituted tetrahydroisoquinoiline derivative, which acts as a D1 positive allosteric modulator. This invention is beneficial as a pharmaceutical agent for treating diseases where D1 receptors play a crucial role. The patent showcases his innovative approach to drug development.
Career Highlights
Jérôme is associated with UCB Biopharma Srl, a company known for its commitment to advancing healthcare through innovative solutions. His work at UCB Biopharma Srl has allowed him to focus on groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Jérôme has collaborated with talented individuals such as Ali Ates and David Skolc. These partnerships have contributed to the success of his projects and the advancement of their shared goals in the field of pharmaceuticals.
Conclusion
Jérôme Albert J Hoet's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for new treatments and advancements in healthcare.